| The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation. (NCT05097274) | Institute of Cancer Research, United Kingdom | 2015-10-15 |
| Radiation Treatment of Lymph Node Recurrence From Prostate Cancer : is 11C-choline PET/CT Predictive of Survival Outcomes? (NCT06170164) | IRCCS San Raffaele | 2015-10-08 |
| The Investigation of New Biological Markers for Prostate Cancer Diagnosis and Management in Chinese Population (NCT03893929) | Chinese University of Hong Kong | 2015-10-07 |
| MRI-Based Active Surveillance to Avoid the Risks of Serial Biopsies in Men With Low-Risk Prostate Ca (NCT02564549) | Virginia Commonwealth University | 2015-10-05 |
| Understanding the Value of Community Vital Signs in Primary Care (NCT02512835) | Virginia Commonwealth University | 2015-10-01 |
| Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer (NCT02353819) | University of Texas Southwestern Medical Center | 2015-10-01 |
| Phase III Radium 223 mCRPC-PEACE III (NCT02194842) | European Organisation for Research and Treatment of Cancer - EORTC | 2015-10-01 |
| HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate Cancer (NCT02628041) | CHU de Quebec-Universite Laval | 2015-10-01 |
| Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté (NCT02626377) | Centre Hospitalier Universitaire de Besancon | 2015-10-01 |
| Japanese Research for Patients With Non-metastatic Castration Resistant Prostate Cancer - Enzalutamide (NCT02588001) | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | 2015-10-01 |
| Perception of Cohesion Within a Relationship (Dyadic Adjustment) on the Quality of Life of Patients With Prostate Cancer With Gonadotropin-releasing Hormone. (NCT02630641) | Ipsen | 2015-10-01 |
| Hormonal Therapy and Chemotherapy Followed by Prostatectomy in Patients With Prostate Cancer (NCT02494713) | The University of Texas Health Science Center, Houston | 2015-10-01 |
| Functional Medical Imaging Quantization in Prostate Cancer (NCT03376360) | University Hospital, Brest | 2015-10-01 |
| Radium 223 Following Intermittent ADT (NCT02656563) | Canadian Urology Research Consortium | 2015-10-01 |
| Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours (NCT02804815) | University College, London | 2015-10-01 |
| Decipher Genomics Resource for Intelligent Discovery (NCT02609269) | GenomeDx Biosciences Corp | 2015-10-01 |
| Discovery of Biomarkers for Intrinsic Radiation Sensitivity in Cancer Patients (NCT04340024) | National Cancer Centre, Singapore | 2015-09-30 |
| MRI Assisted Focal Boost With HDR Monotherapy for Prostate Cancer Patients (NCT02623933) | Sunnybrook Health Sciences Centre | 2015-09-24 |
| 68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer (NCT02559115) | Memorial Sloan Kettering Cancer Center | 2015-09-21 |
| Focal Laser Ablation of Prostate Tissue (NCT02357121) | Jonsson Comprehensive Cancer Center | 2015-09-17 |
| Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery) (NCT02742675) | Fudan University | 2015-09-01 |
| Lung Protective Ventilation During Robotic Assisted Prostatectomy (NCT02551341) | Jørgen Bjerggaard Jensen | 2015-09-01 |
| Radical Prostatectomy and External Beam Radiotherapy in mCRPC With 223Radium-dicloride (RaProRad) (NCT04110782) | Azienda Policlinico Umberto I | 2015-09-01 |
| Accuracy of mpMRI and MRI-targeted, Ultrasound-navigated Prostate Fusion Biopsy in Detection of Prostate Cancer (NCT03615131) | Kantonsspital Winterthur KSW | 2015-09-01 |
| Changes of Immunologic Function in Patients of Prostate Cancer Induced After Cryoablation. (NCT02739048) | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | 2015-09-01 |
| Prospective Prolaris Value and Efficacy (NCT03152448) | Myriad Genetic Laboratories, Inc. | 2015-09-01 |
| Safety Study of MGD009 in B7-H3-expressing Tumors (NCT02628535) | MacroGenics | 2015-09-01 |
| Cellular Effect of Cholesterol-Lowering Prior to Prostate Removal (NCT02534376) | Cedars-Sinai Medical Center | 2015-09-01 |
| Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors (NCT02600156) | Mayo Clinic | 2015-09-01 |
| Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device (NCT02524860) | Focal Healthcare Inc. | 2015-09-01 |
| Copper Cu 64 TP3805 PET in Detecting Prostate Cancer in Patients With Persistently Elevated PSA (NCT02989623) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2015-09-01 |
| Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC (NCT02577627) | Optimata Ltd. | 2015-09-01 |
| Hemiablative Focal Brachytherapy Pilot Study (NCT02643511) | St George Hospital, Australia | 2015-09-01 |
| Impact of Yoga As Complementary Therapy in Patients Undergoing Radical Prostatectomy (NCT02620033) | The University of Texas Health Science Center at San Antonio | 2015-09-01 |
| Phase II Study of Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy for Prostate Cancer (NCT02570919) | Fundacao Champalimaud | 2015-09-01 |
| Treatment Patterns in Castrate Resistant Prostate Cancer Patients With Bone Metastases in a Medicare Population (NCT02518698) | Bayer | 2015-08-31 |
| A Phase I Study of a DNA Vaccine Encoding Androgen Receptor Ligand-Binding Domain (AR LBD) +/-GMCSF (NCT02411786) | University of Wisconsin, Madison | 2015-08-24 |
| Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate Cancer (NCT02555397) | Henry Ford Health System | 2015-08-01 |
| Volume Controlled Ventilation vs Autoflow-volume Controlled Ventilation (NCT02512120) | Korea University Anam Hospital | 2015-08-01 |
| Monitoring and Mapping of Erectile Nerve During RALP (MMEN Study) (NCT02507427) | Seoul National University Hospital | 2015-07-26 |
| Assess Gamma H2AX Positivity in Circulating Prostate Cancer Cells Before and After Radium 223 (NCT02981797) | H. Lee Moffitt Cancer Center and Research Institute | 2015-07-22 |
| Effects of an Interactive ICT-Platform for Assessment and Management of Symptoms in Patients Treated for Prostate Cancer (NCT02477137) | Karolinska Institutet | 2015-07-20 |
| Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate Cancer (NCT02362451) | National Cancer Institute (NCI) | 2015-07-10 |
| Men With Metastatic Castrate-Resistant Prostate Cancer Treated With Either Sipuleucel-T (Provenge®), Abiraterone Acetate (Zytiga®) or Enzalutamide (Xtandi®) Undergoing Cardiopulmonary EXercise Testing (NCT02353715) | Duke University | 2015-07-07 |
| J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts (NCT02552394) | Weill Medical College of Cornell University | 2015-07-01 |
| Prostate Cancer E-Health-Tutorial (NCT02503748) | Zurich University of Applied Sciences | 2015-07-01 |
| Measuring the Effect of Radiation Therapy on Patient Activity Levels (NCT02694380) | University of Pittsburgh | 2015-07-01 |
| Feasibility of Measuring Exercise's Effects on Molecular Mechanisms of Disease Progression in Prostate Cancer (NCT02481648) | Vancouver Prostate Centre | 2015-07-01 |
| Metformin And Longevity (NCT02511665) | Guy's and St Thomas' NHS Foundation Trust | 2015-07-01 |
| Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer (NCT02514213) | Inovio Pharmaceuticals | 2015-07-01 |
| Reducing Sedentary Behavior Among Prostate Cancer Survivors on Androgen Deprivation Therapy (NCT03321149) | University of Illinois at Urbana-Champaign | 2015-07-01 |
| Development and Validation of Novel MRI Methods for the Detection of Prostate Cancer Aggressiveness (NCT02545881) | Turku University Hospital | 2015-07-01 |
| Pharmacokinetics of Degarelix in Chinese Patients With Prostate Cancer (NCT02468284) | Ferring Pharmaceuticals | 2015-07-01 |
| Assessment of Prostate MRI Before Prostate Biopsies (NCT02485379) | Hospices Civils de Lyon | 2015-07-01 |
| Towards Optimal Prescription of Chemotherapy in Prostate Cancer (NCT02512185) | University Health Network, Toronto | 2015-07-01 |
| Feasibility of a Consumer Based Accelerometer in Monitoring Outpatient Physical Activity: A Study in Patients With Cancer and Amyotrophic Lateral Sclerosis (NCT02457715) | Duke University | 2015-07-01 |
| Incorporating MR Imaging Into Prostate Radiotherapy Treatment Planning (NCT02470910) | Dana-Farber Cancer Institute | 2015-07-01 |
| Pelvic Floor Muscles Training in Men Undergoing Radiotherapy for Prostate Cancer: Randomized Controlled Trial (NCT01762956) | University of Sao Paulo | 2015-07-01 |
| Cancer Diagnosis by Multiparametric UltraSound of the Prostate (NCT02712684) | University College, London | 2015-07-01 |
| Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate Cancer (NCT02499848) | Sophiris Bio Corp | 2015-07-01 |
| Study to Evaluate the Presence of Lower Urinary Tract Symptoms (LUTS) in Prostate Cancer Patients Scheduled to Receive Luteinizing Hormone Releasing Hormone (LHRH) Analogues (NCT02542501) | Ipsen | 2015-07-01 |
| Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer (NCT02654938) | Panacela Labs LLC | 2015-07-01 |
| Physical Therapy for Men Undergoing Prostatectomy (NCT02558946) | Indiana University | 2015-06-29 |
| DMH-Based Plan Evaluation and Inverse Optimization in Radiotherapy (NCT02663817) | University of Miami | 2015-06-19 |
| Quantitative Prostate Cancer Contrast-enhanced Ultrasound (NCT02295449) | Hospices Civils de Lyon | 2015-06-09 |
| ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC) (NCT02325557) | Advaxis, Inc. | 2015-06-04 |
| Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer (NCT02430480) | National Cancer Institute (NCI) | 2015-06-03 |
| Radium-223 in Combination With Enzalutamide (NCT02225704) | Cancer Trials Ireland | 2015-06-03 |
| Web-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8 (NCT02470936) | University of California, San Francisco | 2015-06-01 |
| Linear Source Registry for Prostate Cancer (NCT02516709) | CivaTech Oncology | 2015-06-01 |
| Ipilimumab and GMCSF Immunotherapy for Prostate Cancer (NCT01530984) | Lawrence Fong | 2015-06-01 |
| A Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPC (NCT02438007) | LTN PHARMACEUTICALS, INC. | 2015-06-01 |
| Carbon-11 Labeled Sarcosine in Prostate Cancer (NCT02462447) | University of Michigan | 2015-06-01 |
| Ethnographic Study of the Everyday Life of Men With Prostate Cancer, Focusing on Diet, Activities and Digital Behavior (NCT03692585) | Danish Cancer Society | 2015-06-01 |
| Multi-Center Randomized Clinical Trial Irreversible Electroporation for the Ablation of Localized Prostate Cancer (NCT01835977) | Clinical Research Office of the Endourological Society | 2015-06-01 |
| Evaluation of Clarity Ultrasound Guidance for Prostate Therapy (NCT02388308) | Institute of Cancer Research, United Kingdom | 2015-05-15 |
| Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY (NCT02269982) | Duke University | 2015-05-14 |
| Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 (NCT02362464) | National Cancer Institute (NCI) | 2015-05-12 |
| Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. (NCT02445976) | Innocrin Pharmaceutical | 2015-05-01 |
| Pillars4Life Trial (NCT02465892) | Duke University | 2015-05-01 |
| Prospective RCT on Post Prostatectomy Urine Leak (NCT02367404) | Institut Mutualiste Montsouris | 2015-05-01 |
| Effectiveness of Community-based Football in Prostate Cancer (NCT02430792) | Rigshospitalet, Denmark | 2015-05-01 |
| Impact of Radical Prostatectomy as Primary Treatment in Patients With Prostate Cancer With Limited Bone Metastases (NCT02454543) | Martini-Klinik am UKE GmbH | 2015-05-01 |
| Survivorship Promotion In Reducing IGF-1 Trial (NCT02431676) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-05-01 |
| Phase I Clinical Trial of Cryoimmunotherapy Against Prostate Cancer (NCT02423928) | Alden Cancer Therapy II | 2015-05-01 |
| PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer (NCT02483884) | Lantheus Biosciences Ltd. | 2015-05-01 |
| Evaluation of a New Radiotracer (68Ga-NOTA-AE105) for Diagnosing Aggressive Cancer With Positron Emission Tomography (NCT02437539) | Rigshospitalet, Denmark | 2015-05-01 |
| Transperineal, MRI-guided, Prostate Biopsy (NCT02651948) | University Hospital, Strasbourg, France | 2015-05-01 |
| Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer (NCT02409212) | Sheffield Teaching Hospitals NHS Foundation Trust | 2015-05-01 |
| Micro RNAs to Predict Response to Androgen Deprivation Therapy (NCT02366494) | Medical College of Wisconsin | 2015-04-29 |
| Optimizing Veteran-Centered Prostate Cancer Survivorship Care (NCT01900561) | VA Office of Research and Development | 2015-04-17 |
| A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer (NCT02391480) | AbbVie | 2015-04-14 |
| Adaptive Abiraterone Therapy for Metastatic Castration Resistant Prostate Cancer (NCT02415621) | H. Lee Moffitt Cancer Center and Research Institute | 2015-04-13 |
| 11C- and 18F-Choline PET/MR Imaging for Prostate Cancer (NCT02397408) | University of California, San Francisco | 2015-04-09 |
| Relationship of Mitochondrial Enzymes With Cancer Related Fatigue (NCT02414971) | University of Florida | 2015-04-01 |
| A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer (NCT02346526) | Massachusetts General Hospital | 2015-04-01 |
| Active Surveillance in Prostate Cancer, Imaging to Detect Radiographic Progression as an Endpoint (ASPIRE) (NCT02425592) | Yale University | 2015-04-01 |
| Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy (NCT02408497) | National Cancer Centre, Singapore | 2015-04-01 |
| Salvage Brachytherapy and Interstitial Hyperthermia for Locally Recurrent Prostate Carcinoma Following Radiation Therapy (NCT03238066) | University of Erlangen-Nürnberg Medical School | 2015-04-01 |
| Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer (NCT02441894) | Sanofi | 2015-04-01 |